METASTATIC BLADDER CARCINOMA
Clinical trials for METASTATIC BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy aims to tame immunotherapy side effects in advanced cancers
Disease control OngoingThis study tests whether adding tocilizumab to two standard immunotherapy drugs (ipilimumab and nivolumab) can reduce severe side effects while still fighting cancer. About 35 adults with advanced melanoma, non-small cell lung cancer, or bladder cancer will receive the combinatio…
Matched conditions: METASTATIC BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 07:03 UTC
-
New hope for tough bladder cancers: drug targets DNA repair flaws
Disease control TerminatedThis study tests a drug called olaparib in people with advanced bladder or other genitourinary cancers that have specific DNA-repair defects. Olaparib works by blocking a protein that cancer cells need to repair their damaged DNA, which may stop the cancer from growing. The trial…
Matched conditions: METASTATIC BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:40 UTC